Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease
Objective: To investigate (1) the domains of cognitive impairment in patients with Parkinson's disease (PD) and rapid eye movement sleep behavior disorder (RBD). (2) To…Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET
Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease
Objective: The objective of this study was to assess the frequency of suicidal ideation and suicide attempts in a sample of consecutive patients with Parkinson's…Dropped head syndrome in parkinsonism: Two treatable etiologies not to miss
Objective: To report the etiology of treatable head drop in Parkinson's disease (PD): one patient from rotigotine patch and the other two from neck extensor…Handwriting in Parkinson′s disease: Systematic review and preliminary study
Objective: To define objective handwriting change in Parkinson's disease (PD) with emphasis on the early stages. Background: Handwriting is a complex activity that requires precision…The high prevalence of pain among patients with X linked dystonia parkinsonism
Objective: To evaluate the frequency of pain and its severity among XDP (X linked dystonia parkinsonism) patients. Background: Sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag") is…Comparing quality of PD care in a comprehensive clinic to specialist care
Objective: To compare the quality of care according to the AAN quality indicators for PD through a comprehensive PD care model vs. an academic movement…Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease
Objective: The present study evaluated the therapeutic potentials of apocyanin for the treatment of neurobehavioral consequences in LPS induced PD model. Background: Parkinson's disease (PD),…Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists
Objective: To investigate the association between dopamine receptor D types 2(DRD2) (CA)n and types 3 (DRD3) Ser9Gly polymorphisms and the risk of Parkinson's disease (PD),…A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach
Objective: To evaluate the safety and efficacy of incobotulinumtoxinA (IncoA) injection in the tremor of Parkinson's disease (PD). Background: Unlike other cardinal motor features of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.